8-93765573-CA-C
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_153704.6(TMEM67):c.579delA(p.Gly195AspfsTer27) variant causes a frameshift, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000011 in 1,459,010 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_153704.6 frameshift, splice_region
Scores
Clinical Significance
Conservation
Publications
- ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- COACH syndrome 1Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
- Meckel syndrome, type 3Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
- nephronophthisis 11Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- COACH syndrome 1Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
- Joubert syndrome 6Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Joubert syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Meckel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Senior-Boichis syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TMEM67 | NM_153704.6 | c.579delA | p.Gly195AspfsTer27 | frameshift_variant, splice_region_variant | Exon 6 of 28 | ENST00000453321.8 | NP_714915.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TMEM67 | ENST00000453321.8 | c.579delA | p.Gly195AspfsTer27 | frameshift_variant, splice_region_variant | Exon 6 of 28 | 1 | NM_153704.6 | ENSP00000389998.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251350 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1459010Hom.: 0 Cov.: 29 AF XY: 0.0000124 AC XY: 9AN XY: 726080 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Meckel syndrome, type 3 Pathogenic:2
- -
- -
Meckel-Gruber syndrome;C0431399:Joubert syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gly195Aspfs*27) in the TMEM67 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TMEM67 are known to be pathogenic (PMID: 20232449, 23559409). This variant is present in population databases (rs386834203, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with Meckel–Gruber syndrome (PMID: 17377820, 34032358). ClinVar contains an entry for this variant (Variation ID: 56784). For these reasons, this variant has been classified as Pathogenic. -
TMEM67-related disorder Pathogenic:1
The TMEM67 c.579delA variant is predicted to result in a frameshift and premature protein termination (p.Gly195Aspfs*27). This variant was reported in the compound heterozygous state in at least two individuals with Meckel syndrome (Consugar et al. 2007. PubMed ID: 17377820; Hu et al. 2021. PubMed ID: 34032358). This variant is reported in 0.0054% of alleles in individuals of East Asian descent in gnomAD. Frameshift variants in TMEM67 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at